Vividion Therapeutics, Inc.
Clinical trials sponsored by Vividion Therapeutics, Inc., explained in plain language.
-
First human trial launches for promising new cancer pill
Disease control Recruiting nowThis is a first-in-human study to test the safety and early effectiveness of a new oral drug called VVD-133214. It will be given alone and in combination with an existing immunotherapy (pembrolizumab) to people with advanced solid tumors that have specific genetic features known …
Phase: PHASE1 • Sponsor: Vividion Therapeutics, Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:10 UTC
-
First patients to receive new experimental cancer pill
Disease control Recruiting nowThis is the first study in people to test a new oral drug called VVD-159642, which is designed to block specific cancer growth signals. It will enroll about 220 adults with advanced solid tumors that have spread or cannot be removed by surgery. The main goals are to find a safe d…
Phase: PHASE1 • Sponsor: Vividion Therapeutics, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
First human trial launches for new Cancer-Fighting drug
Disease control Recruiting nowThis is the first human study of an experimental drug called VVD-130037 for people with advanced solid tumors that have stopped responding to standard treatments. The trial aims to find the safest dose and see how the drug affects the body, both alone and when combined with other…
Phase: PHASE1 • Sponsor: Vividion Therapeutics, Inc. • Aim: Disease control
Last updated Mar 09, 2026 14:23 UTC